NASDAQ:GHSI
Guardion Health Sciences, Inc.
- Stock
Last Close
9.71
26/07 20:00
Market Cap
12.73M
Beta: 0.86
Volume Today
1.17K
Avg: 18.67K
PE Ratio
−0.46
PFCF: −2.33
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|
average inventory | 37.28K - | 99.36K 166.53% | 256.36K 158.00% | 334.47K 30.47% | 347.96K 4.03% | 376.33K 8.15% | 1.74M 363.30% | 2.90M 66.23% | ||
average payables | 314.17K - | 333.85K 6.27% | 362.58K 8.61% | 271.53K 25.11% | 368.72K 35.80% | 424.83K 15.22% | 879.70K 107.07% | 1.07M 21.19% | ||
average receivables | 1.40K - | 37.22K 2,550.20% | 50.49K 35.64% | 53.27K 5.51% | 44.79K 15.91% | 711.41K 1,488.23% | 1.67M 134.46% | 2.10M 25.86% | ||
book value per share | -16.80 - | -4.73 71.85% | 94.01 2,088.08% | 43.10 54.15% | 98.98 129.63% | 29.86 69.83% | 47.06 57.60% | 10.78 77.09% | 6.41 40.55% | |
capex per share | -0.03 - | -0.05 55.13% | -0.51 1,011.51% | -4.20 722.83% | -1.41 66.47% | -0.14 89.85% | -0.16 10.21% | -0.00 97.10% | -0.00 34.56% | |
capex to depreciation | -0.04 - | -0.06 38.65% | -0.31 462.48% | -1.05 234.43% | -0.27 73.95% | -0.19 32.15% | -0.08 55.69% | -0.00 94.57% | -0.20 4,279.01% | |
capex to operating cash flow | 0.00 - | 0.00 6.93% | 0.01 439.99% | 0.07 578.64% | 0.03 61.83% | 0.01 82.08% | 0.01 37.87% | 0.00 89.33% | 0.00 16.04% | |
capex to revenue | -0.02 - | -0.02 24.09% | -0.09 258.42% | -0.33 286.31% | -0.19 42.46% | -0.02 88.62% | -0.01 52.15% | -0.00 95.11% | -0.00 38.57% | |
cash per share | 0.19 - | 0.86 351.41% | 64.80 7,473.94% | 9.08 85.99% | 91.44 907.29% | 29.88 67.33% | 19.19 35.78% | 8.72 54.53% | 5.00 42.64% | |
days of inventory on hand | 222.79 - | 212.14 4.78% | 321.86 51.72% | 328.17 1.96% | 332.52 1.33% | 72.18 78.29% | 32.55 54.90% | 174.38 435.67% | 142.16 18.48% | |
days payables outstanding | 1.98K - | 1.72K 13.27% | 647.41 62.33% | 379.43 41.39% | 138.09 63.61% | 114.06 17.40% | 21.37 81.27% | 84.86 297.15% | 32.61 61.57% | |
days sales outstanding | 3.68 - | 4.33 17.80% | 60.73 1,302.63% | 10.93 82.01% | 31.67 189.82% | 2.17 93.14% | 71.23 3,178.89% | 63.57 10.76% | 67.78 6.62% | |
debt to assets | 3.14 - | 0.27 91.32% | 0.00 98.48% | 0.05 - | 0.04 3.17% | 0.00 97.48% | 0.00 84.18% | |||
debt to equity | -0.63 - | -0.21 67.14% | 0.00 102.15% | 0.05 - | 0.05 4.77% | 0.00 97.71% | 0.00 75.23% | |||
dividend yield | 0.00 - | |||||||||
earnings yield | -0.11 - | -0.07 34.98% | -0.07 7.71% | -0.10 44.76% | -1.39 1,358.20% | -0.24 82.59% | -1.61 568.09% | -3.42 111.78% | 0.02 100.68% | |
enterprise value | 81.44M - | 80.69M 0.92% | 75.97M 5.84% | 80.93M 6.52% | -2.51M 103.10% | 27.42M 1,193.90% | 11.26M 58.93% | -1.80M 115.96% | 426.67K 123.74% | |
enterprise value over ebitda | -10.47 - | -22.19 111.91% | -14.72 33.69% | -13.84 5.97% | 0.29 102.08% | -3.31 1,252.13% | -1.18 64.47% | -1.07 9.12% | -0.11 89.82% | |
ev to operating cash flow | -71.45 - | -48.80 31.71% | -22.32 54.26% | -19.39 13.14% | 0.42 102.14% | -3.42 923.09% | -1.06 69.08% | 0.24 122.81% | -0.10 140.46% | |
ev to sales | 721.88 - | 572.13 20.74% | 173.71 69.64% | 85.89 50.55% | -2.78 103.23% | 14.51 622.65% | 1.56 89.27% | -0.16 110.45% | 0.03 121.42% | |
free cash flow per share | -15.63 - | -22.67 45.10% | -47.09 107.67% | -60.67 28.85% | -51.01 15.92% | -28.25 44.62% | -22.62 19.91% | -6.10 73.03% | -3.44 43.60% | |
free cash flow yield | -0.01 - | -0.02 45.10% | -0.04 107.67% | -0.05 28.85% | -0.77 1,306.48% | -0.23 70.64% | -0.70 208.24% | -0.84 20.34% | -0.64 23.42% | |
graham net net | -19.75 - | -7.14 63.84% | 59.76 936.88% | 5.08 91.49% | 86.25 1,596.52% | 25.86 70.02% | 19.35 25.16% | 4.21 78.25% | 4.43 5.30% | |
graham number | 213.84 - | 91.48 57.22% | 391.87 328.34% | 319.25 18.53% | 451.69 41.49% | 142.18 68.52% | 235.18 65.40% | 77.55 67.03% | 4.23 94.54% | |
income quality | 0.13 - | 0.29 123.14% | 0.64 123.04% | 0.54 16.25% | 0.55 3.16% | 0.93 68.66% | 0.43 53.99% | 0.50 16.01% | -27.65 5,640.97% | |
intangibles to total assets | 0 - | 0 | 0.30 Infinity% | 0.55 85.13% | 0.00 99.29% | 0.01 30.58% | 0.48 9,362.03% | 0 100% | 0 | |
interest coverage | -8.48 - | -3.57 57.90% | -222.59 6,131.24% | -2.68K 1,105.80% | -34.58 98.71% | -1.18K 3,301.54% | 0.03 - | |||
interest debt per share | 20.86 - | 16.09 22.86% | 0.74 95.39% | 0.03 95.83% | 6.95 22,336.70% | 1.55 77.69% | 0.05 96.46% | 12.58 22,789.87% | ||
inventory turnover | 1.64 - | 1.72 5.02% | 1.13 34.09% | 1.11 1.92% | 1.10 1.31% | 5.06 360.66% | 11.21 121.74% | 2.09 81.33% | 2.57 22.66% | |
invested capital | -0.63 - | -0.21 67.14% | 0.00 102.15% | 0.05 - | 0.05 4.77% | 0.00 97.71% | 0.00 75.23% | |||
market cap | 80.68M - | 80.68M 0% | 80.68M 0% | 81.60M 1.14% | 8.02M 90.17% | 35.50M 342.47% | 15.33M 56.83% | 8.85M 42.23% | 6.79M 23.36% | |
net current asset value | -1.41M - | -470.06K 66.63% | 4.58M 1,074.32% | 609.58K 86.69% | 11.02M 1,708.24% | 7.75M 29.70% | 10.91M 40.74% | 13.12M 20.29% | 8.11M 38.16% | |
net debt to ebitda | -0.10 - | -0.00 97.50% | 0.91 37,500.68% | 0.11 87.41% | 1.21 952.02% | 0.98 19.14% | 0.42 56.47% | -6.33 1,590.92% | 1.62 125.60% | |
net income per share | -120.98 - | -78.66 34.98% | -72.60 7.71% | -105.09 44.76% | -91.61 12.83% | -30.09 67.16% | -52.23 73.60% | -24.79 52.54% | 0.12 100.50% | |
operating cash flow per share | -15.60 - | -22.63 45.08% | -46.58 105.84% | -56.47 21.25% | -49.61 12.16% | -28.11 43.34% | -22.47 20.06% | -6.10 72.86% | -3.44 43.60% | |
payables turnover | 0.18 - | 0.21 15.30% | 0.56 165.48% | 0.96 70.63% | 2.64 174.77% | 3.20 21.07% | 17.08 433.80% | 4.30 74.82% | 11.19 160.22% | |
receivables turnover | 99.31 - | 84.30 15.11% | 6.01 92.87% | 33.41 455.85% | 11.53 65.50% | 168.02 1,357.67% | 5.12 96.95% | 5.74 12.06% | 5.39 6.21% | |
research and ddevelopement to revenue | 3.56 - | 0.45 87.26% | 0.59 30.68% | 0.25 58.52% | 0.22 12.55% | 0.09 60.42% | 0.01 89.55% | 0.02 97.12% | 0.01 29.86% | |
return on tangible assets | -35.97 - | -21.94 39.02% | -1.02 95.34% | -4.68 357.00% | -0.87 81.43% | -0.87 0.71% | -2.03 131.86% | -1.40 31.14% | 0.01 100.95% | |
revenue per share | 1.54 - | 1.93 25.01% | 5.98 210.11% | 12.75 113.00% | 7.43 41.73% | 6.63 10.77% | 15.27 130.35% | 9.05 40.74% | 9.64 6.53% | |
roe | 7.20 - | 16.63 130.96% | -0.77 104.64% | -2.44 215.75% | -0.93 62.04% | -1.01 8.85% | -1.11 10.15% | -2.30 107.19% | 0.02 100.84% | |
roic | 12.51 - | 17.16 37.13% | -0.77 104.46% | -1.53 99.38% | -0.69 54.61% | -0.91 31.68% | -0.47 48.57% | 0.07 114.21% | -0.48 826.21% | |
sales general and administrative to revenue | 49.74 - | 23.46 52.84% | 10.71 54.34% | 5.24 51.09% | 8.22 57.01% | 3.62 56.03% | 1.55 57.16% | 0.87 44.04% | 0.64 25.82% | |
shareholders equity per share | -16.80 - | -4.73 71.85% | 94.01 2,088.08% | 43.10 54.15% | 98.98 129.63% | 29.86 69.83% | 47.06 57.60% | 10.78 77.09% | 6.41 40.55% | |
stock based compensation to revenue | 43.31 - | 12.55 71.01% | 4.84 61.47% | 1.69 65.00% | 3.01 77.79% | -0.21 106.98% | -0.08 - | |||
tangible asset value | -1.23M - | -345.57K 71.85% | 4.69M 1,456.01% | 1.17M 75.11% | 11.98M 927.48% | 8.47M 29.35% | 11.04M 30.44% | 13.17M 19.25% | 8.15M 38.14% | |
tangible book value per share | -16.80 - | -4.73 71.85% | 64.12 1,456.01% | 15.78 75.39% | 98.57 524.72% | 29.69 69.88% | 23.31 21.50% | 10.78 53.74% | 6.41 40.55% | |
working capital | -892.24K - | -470.06K 47.32% | 4.58M 1,074.32% | 609.58K 86.69% | 11.46M 1,779.56% | 8.02M 29.99% | 10.91M 36.02% | 17.63M 61.55% | 10.57M 40.05% |
All numbers in USD (except ratios and percentages)